IKT - Inhibikase Therapeutics Inc
IEX Last Trade
1.39
0.003 0.252%
Share volume: 3,098
Last Updated: Fri 30 Aug 2024 08:39:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.39
0.00
0.25%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-12 | 2022-11-14 | 2023-03-31 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-27 | 2024-05-15 | |
Cash flow financing | 0.000 | 0.000 | 0.000 | 8.579 M | -35.986 K | 70.000 | -138.104 K | 366.999 K | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -4.356 M | -5.505 M | -3.556 M | -5.972 M | -4.565 M | -4.105 M | -3.442 M | -3.867 M | |
Net income | -4.640 M | -4.495 M | -4.279 M | -4.478 M | -5.778 M | -4.595 M | -4.178 M | -4.650 M | |
Depreciation | 0.000 | 1.681 K | 5.042 K | 5.043 K | 159.204 K | 6.583 K | 6.568 K | 6.568 K | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 6.552 K | 13.842 K | 39.881 K | 64.521 K | 79.604 K | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -43.089 K | -20.926 M | 4.963 M | -5.839 M | 2.550 M | 17.061 M | -2.116 M | -3.312 M | |
Net Borrowings | -33.943 M | -27.598 M | -23.980 M | -27.239 M | -21.606 M | -17.281 M | -13.589 M | -10.318 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -43.089 K | -200.166 K | 0.000 | 0.000 | -14.238 K | 0.000 | 0.000 | 0.000 | |
Cash Change | 32.212 M | 26.534 M | 23.050 M | 25.718 M | 20.935 M | 16.832 M | 13.252 M | 9.749 M |